Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	-	-	-

Company Profile for Reunion Neuroscience Inc. Share

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Company Data

Name Reunion Neuroscience Inc.

Company Reunion Neuroscience Inc.

Symbol REUN

Website https://www.fieldtriphealth.com

Primary Exchange

NASDAQ

ISIN CA76134G1037

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Gregory T. Mayes Esq., J.D.

Market Capitalization 13 Mio

Country Canada

Currency USD

Employees 0,0 T

Address 30 Duncan Street, M5V 2C3 Toronto

IPO Date 2020-10-07

ID Changes

Date	From	To
17.08.2022	FTRP	REUN

Ticker Symbols

Name	Symbol
NASDAQ	REUN

More Shares

Investors who Reunion Neuroscience Inc. hold also have the following shares in their portfolio:

BERN KT. 12-27 Bond

WISDOMTREE INTERNATIONAL MIDCAP DIVIDEND FUND ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog